F or the treatment of cerebral metastases, indication for surgery is currently limited to a subgroup of patients. Although radiosurgery and resection have been shown to be equivalent in terms of survival, some studies have shown that radiosurgery leads to better local control due to its effect on the infiltration zone surrounding the lesion and whole brain radiation therapy is associated with significantly shorter survival.
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F or the treatment of cerebral metastases, indication for surgery is currently limited to a subgroup of patients. Although radiosurgery and resection have been shown to be equivalent in terms of survival, some studies have shown that radiosurgery leads to better local control due to its effect on the infiltration zone surrounding the lesion and whole brain radiation therapy is associated with significantly shorter survival. 26, 27 Nevertheless, in many patients who have focal deficits resulting from metastases, resection is still undertaken in order to achieve rapid improvement in neurological function. Metastases within or close to the motor cortex or subcortical motor tracts may therefore be treated by resection.
Intraoperative neuromonitoring is routinely used for resection of gliomas in or adjacent to the motor system. 15, 22, 33 Cerebral metastases, however, are generally believed to be noninfiltrative, and IOM during resection of these lesions in motor-eloquent regions is still not widely described. 29 As recent studies have shown that cerebral metastases also infiltrate surrounding brain tissue, intraoperative surveillance of the motor systems might be helpful to reduce surgery-related motor deficits. 25, 26, 28 Motor evoked potential monitoring allows us to identify crucial steps during resection of tumors within the rolandic region or tumors adjacent to the pyramidal tract. 5, 19, 21, 24, 33 Furthermore, several studies have shown that MEP moniReliability of intraoperative neurophysiological monitoring using motor evoked potentials during resection of metastases in motor-eloquent brain regions toring reduces the rate of surgery-related neurological deficits while potentially increasing the extent of resection. 6, 15, 30 However, the literature is still lacking studies on the experience and special characteristics of IOM during surgery for metastases within or close to the motor cortex or subcortical motor tracts. We therefore undertook this study to elucidate the application of IOM during resection of supratentorial metastases in motor-eloquent regions and evaluate cases of false-negative and falsepositive IOM. In addition, we assessed risk factors for a new surgery-related deficit.
Methods

Patients
Between 2006 and 2011 we resected 56 consecutive supratentorial metastases in motor-eloquent areas using monopolar direct cortical stimulation for monitoring of MEPs (Table 1 ). Figure 1 shows examples of the evaluated eloquent lesions. During the same period, resection was performed without IOM in 150 cases of metastases in noneloquent regions of the brain. Topographic association between tumor and corticospinal tract or rolandic cortex was preoperatively assessed by means of MRI.
Eligibility for surgery was discussed on a case-bycase basis by an interdisciplinary tumor board. The indication for surgery required the consent of all disciplines (neurosurgery, neurooncology, radiation oncology, medical oncology) according to the current guidelines.
9,18 Surgery was frequently recommended for patients presenting with disabling motor weakness or lesions resistant to chemo-or radiotherapy.
Patient Evaluation
Preoperatively, all patients underwent MRI for tumor diagnosis, tumor localization, and acquisition of a navigational data set for intraoperative neuronavigation (Brain-LAB Vector Vision 2 or BrainLAB Curve) (Fig. 1 ). All patients were evaluated for muscle strength, coordination, sensory function, and cranial nerve function according to a standardized protocol. Patients were classified according to the recursive partitioning analysis classification, which assigns patients with cerebral metastases to 3 classes: Class 1-KPS score ≥ 70, age < 65 years, controlled primary tumor, no extracranial metastases; Class 3-KPS score < 70; Class 2-all others. 8 After surgery, neurological status was routinely assessed after the patients awakened from anesthesia. Assess ments were conducted daily from the 1st postoperative day until discharge, again at 6-8 weeks postoperatively, and during follow-up on a regular basis every 3-12 months. Any new surgery-related neurological motor deficits were differentiated as permanent or temporary. A new surgery-related permanent deficit was defined as a new or aggravated motor deficit due to surgery that did not resolve to the preoperative status during follow-up. A temporary deficit was defined as a new or aggravated postoperative motor deficit that disappeared during the regular 8-week follow-up interval. However, every patient who presented with a new motor deficit directly after anesthesia underwent a postoperative CT scan to exclude secondary hemorrhage. Furthermore, all patients underwent MRI within 48 hours after surgery to assess the extent of tumor resection and to assess any potential diffusion impairment (ischemia), increasing edema, or hemorrhage to find reasons for new postoperative deficits. During followup, MRI was also performed on a regular basis every 3-12 months depending on the tumor entity and current oncological therapy. Follow-up MRI studies were reviewed for recurrent metastases because the neurological status during follow-up was defined for purposes of this study as neurological status during progression-free survival.
Resection Procedure and IOM
Total intravenous anesthesia was used for all cases, and volatile anesthetic agents were strictly avoided because of interference with IOM. 19, 22, 31 Consequently, propofol and remifentanil were continuously administered for intraoperative anesthesia and analgesia. Neuromuscular blocking by rocuronium was used for intubation only and was avoided during surgery.
Intraoperative monitoring was performed using a strip electrode with 8 contacts (Ad-Tech Medical Instrument Corp. or inomed Medizintechnik), which was positioned onto the rolandic cortex (Fig. 2) . Somatosensory evoked potential phase reversal confirmed the location of the pre-and postcentral gyrus and the central sulcus. 4 Sequential MEP monitoring (every 2-60 seconds) was then performed by anodal direct cortical stimulation of the precentral gyrus until the end of resection and before dural closure as reported previously. 4, 15, 21, 34 Motor evoked potentials were sequentially recorded and observed by a technologist trained as a neurophysiologist. Data were analyzed in real time and monitored for amplitude and latency at least every 60 seconds. Depending on the status of the resection, intervals were shortened to 2 seconds to guarantee maximum safety. Amplitude was evaluated by measuring peak-to-peak differences, whereas latency was defined as the span between the start of the stimulation in a given sequence and the first assessable amplitude. 4, 21, 32, 34 Intraoperatively, an amplitude decrease of 50% from the baseline value was used as the threshold for significant reduction, and a decrease > 50% was immediately reported to the surgeon (if it had not been caused by technical issues). If possible, the surgeon reversed the causal surgical step, spatulas were removed, and the exposed brain was irrigated with warm Ringer solution. Irrigation with nimodipine was used when resection was close to major blood vessels to reverse or avoid impending vasospasm. Tumor resection continued after stabilization or renormalization of MEPs. In cases in which MEPs did not recover, resection was halted at this area of the tumor. Incomplete reduction of CMAP was considered deterioration rather than loss. Latency increase without simultaneous deterioration of amplitude was never seen. Because a 50% decline in amplitude was considered significant intraoperatively, all further data are related to this rule.
Analysis of Monitoring Data
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post hoc with respect to curve characteristics and to evaluate the reliability of IOM according to the patient's postoperative status. Consequently, we investigated amplitude deteriorations and latency increases to identify subsequent temporary or permanent new postoperative motor deficits.
We assessed every amplitude reduction of more than 25% as well as every latency increase of more than 10%. The total number of events of each type was recorded, and for each event, the average value and reversibility were noted.
Ethical Standard
The study is in accordance with ethical standards of the Technical University of Munich and the Declaration of Helsinki. It was also approved by the institutional review board of the Technical University of Munich.
Statistical Analysis
For testing the distribution of several attributes, a chisquare or Fisher exact test was performed. Differences between 2 groups were tested using the Mann-WhitneyWilcoxon test for multiple comparisons on ranks for independent samples. Differences between groups were tested by the Kruskall-Wallis test for nonparametric ANOVA followed by the Dunn test as the post hoc test. All results are presented as mean ± SD. Median and range were also calculated (GraphPad Prism 5.0c); p < 0.05 was considered significant.
Results
Of 56 patients with supratentorial metastases, 24 (43%) were women and 32 (57%) were men. The patients' median age was 63 years (range 24-89 years, mean 61 years). They harbored metastases of lung cancer in 17 cases (30%), breast cancer in 12 (21%), melanoma in 5 (9%), colon cancer in 4 (7%), renal cancer in 4 (7% ), and other primary tumors in 14 (26%). Twenty-five tumors (44%) were located within the right hemisphere, and 31 (56%) within the left hemisphere. In 45 cases (80%) the tumors were newly diagnosed, and in 11 cases (20%), they had been previously treated by radiotherapy. Twentyseven percent of the tumors were frontodorsal (excluding the precentral gyrus) and close to the anterior part of the internal capsule, 37% were in the precentral gyrus, 14% were in the postcentral gyrus, and 22% were adjacent to or within the subcortical pyramidal tract. Thirty-two patients (57%) had single cerebral metastases, 10 (18%) had 38  bronchial  postcentral  yes  irreversible  reversible  -no  44  breast  precentral  no  irreversible  reversible  -yes  52  melanoma  frontal  no  irreversible  reversible  -yes  21  bronchial  postcentral  no  irreversible  reversible  permanent  yes  hemorrhage  17  bronchial  frontal  no  irreversible  irreversible  -yes  29  RCC  precentral  yes  irreversible  irreversible * CUP = carcinoma of unknown primary; GTR = gross-total resection; RCC = renal cell carcinoma; SCLC = small cell lung cancer. † Using amplitude reduction > 50% or > 80% as the criteria for significant decrease. 2, 6 (11%) had 3, and 8 (14%) had more than 3 cerebral metastases. The mean tumor diameter was 2.9 ± 1.6 cm (range 0.8-6.5 cm). The most common initial symptoms were motor weakness (occurring in 32 cases [57%]), and seizures (occurring in 17 [30%]). Dizziness was the initial symptom in 5 cases (9%), and the metastatic lesions were incidental asymptomatic findings during staging scans in 2 cases (4%). For follow-up and evaluation of neurological motor function, we considered neurological status during progression-free survival, only. The mean duration of follow-up was 2.9 ± 4.5 months.
Postoperative Results
In general, only 12.5% of patients suffered from a new permanent and 9% from a temporary motor deficit due to surgery, whereas 21% showed improved strength due to surgery. Gross-total resection was achieved in 93% of the cases (49 cases). Postoperative MRI showed residual or suspected residual tumor in 28% of the cases (14 cases).
Correlation of Tumor Type and Location With Postoperative Deficit
Postoperative temporary or permanent impairment of motor function was not related to the type of the primary tumor (data not shown). However, postoperative temporary and permanent impairment of motor function were related to tumor location. The results are provided in Fig. 3 (p = 0.0209).
Intraoperative Monitoring
In all but 3 cases, IOM was possible; in the 3 cases (7%) in which IOM failed, the patients suffered from severe preoperative paresis. The strip electrode was displaced during resection in another case, but IOM could be continued after repositioning of the stimulation electrode. There were no monitoring-related complications.
Intraoperative MEP Reduction > 50%
Stable MEP Amplitudes. In 13% of cases (7 patients), MEPs were stable, according to the intraoperative impression of the neurophysiologist. This means that no substantial amplitude reduction of more than 50% occurred. Postoperatively, all 7 patients remained at their preoperative neurological status (Fig. 4A) .
Reversible MEP Decline. In 60% (32) of all 53 cases in which IOM was used, MEPs were unstable and dropped more than 50% but recovered. Postoperatively, the patients in 76% of these cases (22 patients) had no new deficit; in 17% (5 cases), the patients showed a new temporary motor deficit; and in 7% (2 cases), the patients demonstrated permanently deteriorated motor function compared with the preoperative status (Fig. 4A) . Those 2 cases with permanent new deficits and recovered MEP changes can be suspected as false-negative IOM results at first glance. How ever, when reviewing these cases we found that both pa tients underwent surgery of metastases within the precentral gyrus. While the first patient suffered from secondary postoperative hemorrhage, the second patient showed no deficit directly after surgery but presented with a paresis of the left arm and an ischemic lesion within the precentral gyrus on the MRI scan on the day after surgery (Fig. 4B) . Therefore, the new deficits of those 2 patients are attributable to secondary events not detectable by IOM during surgery. Figure 4B shows the data without those cases of secondary events. Receiver operating characteristics are shown in Table 2 . In all of the 60% of cases of reversible MEP reduction, resection was temporarily stopped and repositioning of retractors and/or irrigation was initiated. In 6% (2) of these cases, MEP deterioration caused definitive termination of resection. In one of these 2 cases residual tumor was observed on postoperative MRI scans.
Irreversible MEP Decline. An irreversible MEP reduction or loss of more than 50% occurred in 27% of all cases (14 cases). In 11 of the cases in which irreversible MEP decline occurred during resection of the metastatic lesion, the patients had no new surgery-related permanent or temporary deficit. These cases represent false positives of IOM; we were unable to find any reasonable explanation for this phenomenon (Fig. 4A) . However, when evaluating the possibility that the time of IOM after 50% MEP decline may have been insufficient to record any recovery, we found that MEPs were recorded for a median of only 4.7 minutes (mean 7.3 minutes, range 2-27 minutes) after 50% decline.
Intraoperative MEP Reduction > 80%
When the data are analyzed with the threshold for significant amplitude decline set at 80%, MEPs were stable in 56% of cases (30 cases), showed reversible reduction in 38% (20 cases), and showed irreversible reduction in 6% (3 cases) (Fig. 4C) .
Stable MEP Amplitudes. In the 56% of cases (30 cases) in which MEP amplitudes were stable according to IOM, 86% of the patients (26 patients) were neurologically unchanged postoperatively, while 7% (2 patients) showed a new temporary deficit and 7% (2 patients) showed a new permanent deficit.
Reversible MEP Decline. In the cases with reversible MEP reduction, 80% of the patients (16 patients) had no new postoperative deficit, 15% (3 patients) showed a new temporary motor deficit, and 5% (1 patient) had a new permanent motor deficit compared with the preoperative state (Fig. 4C) . Those 2 cases of stable or reversible MEPs with postoperatively new motor deficits coincide with the 2 cases of 50% MEP decline. Again, these cases may be thought to be IOM false negatives at first glance. Figure 4D shows the data without those cases of secondary events. Table 2 shows the receiver operating characteristics.
Irreversible MEP Decline. In those 3 cases with irreversible MEP decline, 2 patients had permanent new motor deficit and 1 patient had no new surgery-related motor deficit. As discussed above, this case in which the patient had no new motor deficit has to be termed a false positive with respect to IOM. We were not able to find any explanation for this observation (Fig. 4C) .
Evaluation of the duration of IOM showed that IOM was recorded for a median of only 7.5 minutes (mean 7.5 minutes, range 6.3-9.2 minutes) after > 80% decline.
Intraoperative MEP Loss
Of the 3 cases with irreversible MEP decline > 80%, 2 cases involved complete MEP losses, and both patients showed permanent new paresis postoperatively (Table 1 ; Fig. 4C and D) .
Postoperative MRI Scans
To exclude secondary events as causes for postoperative motor deterioration in cases in which deterioration occurred despite stable MEP amplitudes, all postoperative MRI studies were reviewed. Among the 12.5% of patients (7 cases) with new permanent motor deficit, there were those 3 cases in which IOM was not possible due to already severe preoperative paresis. In the remaining 4 cases, 2 patients (4%) had intraoperatively irreversible MEP deterioration and 2 patients (4%) had intraoperatively reversible MEP reduction, but there were no patients without significant MEP reduction. In the 2 patients with new permanent motor deficit and irreversible MEP decline, MRI showed hemorrhage within the corticospinal tract. Moreover, both of the patients who had new permanent motor deficit and intraoperatively reversible MEP reduction also had pathological findings on postoperative MRI scans. As mentioned above, one patient suffered from secondary postoperative hemorrhage and another patient presented with secondary paresis and an ischemic lesion within the precentral gyrus (Fig. 5) .
When evaluating the MR images for the 6 falsepositive cases, we identified one case of postoperatively increased edema, while MRI was without pathological findings in the remaining 5 cases. This single case corresponds with the one supposedly false-positive case when using 80% amplitude reduction as the threshold value for significant decline ( Fig. 4C and D) .
Influence of IOM on the Course of the Operation
In 87% of all cases, the neurophysiologist reported significant MEP deterioration of > 50% of baseline amplitude. Significant MEP reduction was observed in 86% of the cases in which postoperative MRI showed complete tumor resection and in all cases with residual metastases. Residual tumor was identified in 29% of cases in which there were significant reductions in MEPs and in no cases in which the MEPs remained stable. Due to the small number of cases, these results failed to show statistical significance. However, regarding the data, there might be some association between MEP deterioration and incomplete resection.
Significant MEP reduction resulted in immediate cessation of resection in 2 cases (4%). There was no significant difference in postoperative new motor deficits between groups (data not shown). The rates of new permanent deficit did not differ significantly between patients who had gross-total resection and those who had subtotal resection (8% and 14%, respectively). In those 6 cases (11%) in which irreversible MEP deterioration occurred during resection of the metastatic lesion without new surgery-related permanent deficit (false-positive MEP reduction), postoperative MRI showed suspected residual tumor in 4 patients (67%). In comparison, the percentage of patients with suspected residual tumor (20% [10 patients]) was significantly lower in the 50 cases without false-positive IOM (Fig. 6, p < 0.05) . None of the patients with false-positive IOM had new paresis, while 28% of the 50 patients without false-positive IOM suffered from new surgery-related motor deficit (Fig. 6, p < 0.05) .
Analysis of IOM Characteristics
When analyzing MEP amplitude characteristics post hoc, we also examined any amplitude reduction of more than 25% as well as any latency prolongation of more than 10%. However, we observed no statistically significant correlation between either temporary or permanent new postoperative motor deficit and mean MEP amplitude reduction, mean duration of reduced MEP, total MEP decline per recorded electrode, mean latency prolongation, or mean time period of MEP latency prolongation.
Discussion
In our study, 21% of patients showed postoperative neurological improvement, which is a quite considerable number of cases. These findings were in accordance with previous studies of patients harboring gliomas in or adjacent to eloquent motor areas. This study, along with related studies, found the rate of development of a new permanent deterioration of motor function to be around 12.5%. 10, 15, 20, 21 The rate of new or aggravated treatmentrelated motor weakness for our series is comparable to some but higher than other series on treatment of stereotactic radiosurgery. 17, 35 However, we have to keep in mind that our series only includes patients who were not eligible for radiotherapy according to the current guidelines due to radioresistant tumors or significant mass effects. 2, 7, 9, 16 Thus, this study does not deal with indications for surgery of brain metastases per se but rather with reliability and usefulness of IOM during resection of these lesions.
Correlation of Tumor Type and Location With Postoperative Deficit
Postoperative temporary or permanent impairment of motor function was not related to the type of primary tumor. However, as expected, postoperative temporary and permanent impairment of motor function was related to tumor location (Fig. 3) . Most patients who suffered from new permanent impairment of motor function after surgery underwent resection of a lesion in the precentral gyrus. Resection of frontodorsal metastases was not associated with new permanent deficits in any case, which suggests that IOM might not be necessary in patients with metastases in this location.
Intraoperative Technique
Throughout electrical stimulation of the motor cortex, the current penetrates the apical dendrites and therefore depolarizes the axons at the proximal internodes. Intraoperative anodal monopolar cortical stimulation therefore causes measurable CMAP in the trunk and extremities, 34 which can be quantified for IOM. 12 In this series, the success rate of MEP monitoring was 93%, which is in agreement with our own previously reported findings and other series. 4, 15, 19, 23, 32 These high rates of reliable application validate the applicability of this method. Nevertheless, we again showed that preoperative high-grade paresis can make the detection of CMAP impossible. 32 The required stimulation intensity for reliable CMAP ranged from 4 to 20 mA. In the majority of cases, a frequency of 350 Hz combined with the "train of five" technique and an impulse time of 0.3 msec were used with a range of 0.2-0.7 msec, depending on the resulting CMAP. 4, 32, 34 The most reliable MEPs were recorded from the thenar and hypothenar muscles due to their larger cortical representation field in the primary motor cortex. With higher stimulus intensities, CMAP of the leg was also detectable in most cases.
Nevertheless, we have to emphasize that the high rate of preexisting paresis does not only alter MEP monitoring, it also makes it much more difficult.
False-Negative Cases
Both patients with supposedly false-negative IOM based on a threshold of 80% amplitude reduction underwent resection within the precentral gyrus and suffered from preoperative paresis. Whereas the first patient suffered from secondary postoperative hemorrhage, the second patient showed no aggravated deficit directly after the operation but developed a new high-grade paresis of the left arm the day after surgery. The MRI study performed on the 1st postoperative day indicated an ischemic lesion within the precentral gyrus (Fig. 5) . Most likely, ischemia occurred because of existing but insufficient perfusion over time rather than as a result of complete vessel obstruction. However, we have to doubt whether IOM would have been able to detect an imminent pathological perfusion at the border of the resection cavity in this case. The detection of such imminent ischemia might have been impaired due to the already preexisting paresis in this case.
In most cases, IOM detected the function of the corticospinal tract during surgery. This is exactly what it is supposed to measure. Temporary and permanent new motor deficits in patients with stable IOM can be adequately explained by secondary events. We therefore observed no real false-negative IOM results. However, attentive postoperative care is necessary in order to detect any abnormality at its earliest stage and avoid sequelae of secondary events.
False-negative IOM has rarely been investigated in the literature. Neuloh et al. 21 reported 2 cases of temporary facial weakness in a series of 73 cases of insular gliomas despite stable MEPs. False-positive results could not be verified. In another series with 70 patients who underwent MEP monitoring during resection of lesions within the motor cortex, false-negative IOM results were mentioned, but no frequency was reported. 11 Our group was able to attribute all cases of potentially false-negative IOM to secondary events in a previously reported series. 15 However, when evaluating the correlation between IOM and functional outcome, we observed the same rate of false-negative cases when we set the threshold for significant MEP reduction at 80% (Table 2) .
False-Positive Cases
Overall, an irreversible MEP decline of more than 50% occurred in 26% of cases. We were most concerned by the 11 cases (21%) in which irreversible MEP reduction occurred during metastasis resection without subsequent new surgery-related permanent deficit ( Fig. 4A  and B) . These cases have to be termed false positive with respect to IOM. Despite thoroughly reviewing IOM data, charts, and anesthesia records, we were not able to find any sensible explanation for this phenomenon. This is even more alarming when we consider that these patients had a significantly higher rate of residual tumor (Fig. 6) .
These 11 patients all suffered from metastases in the white matter within or adjacent to the corticospinal tact. Thus, impairment of MEPs due to mass effects of the metastases during resection with consecutive temporary subcortical hypoperfusion is one explanation. In this case, the intraoperative MEP decline would have saved motor function in these patients, none of whom showed any new postoperative motor deficit. Given the different surgical techniques of one-piece tumor resection, this theory would also explain the much higher rate of falsepositive IOM in the present series compared with glioma surgery when based on the same parameters. However, we also found that the time of continuous IOM after MEP decline was rather short, which might have prevented the detection of MEP recovery.
Intraoperative MEP Reduction > 50% Versus > 80%
When analyzing the data based on a significant MEP reduction being considered a reduction by more than 80%, we only observed one false-positive case. Thus, for IOM during resection of metastases in motor-eloquent areas, an MEP reduction > 80% and not only > 50% has to be considered significant to achieve a better correlation with postoperative outcome (Table 2 ; Fig. 4A-D) .
Influence of IOM on the Course of the Operation
In 87% of all cases, the neurophysiologist reported significant MEP reduction. In 86% of the complete resections, significant MEP deterioration was observed. Deterioration occurred in all cases with suspected residual metastases. In contrast, when comparing those cases with significant MEP reduction to cases with uneventful IOM, residual tumor occurred in 29% of cases with MEP reduction. There was no residual tumor seen on MRI in any patient with stable MEP monitoring. Despite the noticeably small number of cases and the lack of statistical significance, the data indicate that there may be an association between incomplete resection and MEP reduction. It seems reasonable to conclude that by limiting the extent of resection IOM may have prevented development of new postoperative motor deficits in these cases. This is in accordance with the findings of some studies, 21 but contradictory to other studies. 10 Nevertheless, neurological function was preserved in these patients, which is an important goal in terms of preserving the quality of life for patients with lesions in eloquent areas of the brain. In this matter IOM in the resection of metastases is very much comparable to IOM in glioma surgery.
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We have to emphasize that our main goal was not to evaluate decision making in the operating room but to define those IOM changes that correlated best with the postoperative motor outcome.
Analysis of IOM Characteristics
In contrast to previous studies, this study did not show any correlation between functional outcome and minor MEP changes. 11, 15, 19, 32 In combination with the low rate of stable MEPs and the high rate of presumably falsepositive IOM cases, we have to state that IOM for surgery of supratentorial metastases is much more inconsistent than in glioma surgery as explained above. Moreover, we have to emphasize the necessity of multimodal mapping and monitoring, including diffusion tensor imaging fiber tracking, subcortical stimulation, and monitoring of somatosensory evoked potentials, which are able to show proximity of the corticospinal tract or potential changes despite stable MEP amplitudes and might therefore increase the safety of resection. 3, 13, 14, 19 
Potential Changes and Postoperative Outcome
Complications related to IOM were very rare in this series, again pointing to the safety of IOM itself and the algorithms that we used. This study also clearly indicates that all potentially false-negative results in IOM can be explained by secondary hemorrhage or ischemia (Fig.  4A-D) . Cases of permanent motor deficit even with stable MEP amplitudes were adequately explained, and we provided a good explanation for all supposedly false-negative IOM data. Although we cannot prove for sure, this is the best achievable data to rule out false-negative MEP monitoring; more explicit evidence is not achievable. We can thus conclude that a new postoperative motor deficit combined with normal postoperative MRI scan is likely to be transient in nature; in the current study, as well as in previous studies, 15 this deficit was not permanent. Of course, even with stable MEP monitoring we cannot avoid other disabilities such as hemianopia or neglect.
Limitations
Several shortcomings of our series have to be mentioned. We used an intensity stimulation of up to 20 mA in some cases, which might have activated axons caudal to the site of resection. Nonetheless, MEPs were stable in these cases, and the patients suffered from no new neurological deficit. The routinely used stimulation intensity was 6-12 mA. Additionally, the absence of intraoperative electrocorticography for monitoring of preseizure afterdischarges due to direct cortical stimulation makes it impossible to rule out intraoperative seizures as a confounding factor in the acquired IOM data.
Conclusions
Reduction of MEP amplitude correlated better with postoperative motor function when an amplitude decline > 80% was considered as a warning criterion than when using an amplitude reduction > 50%. Our results indicate that in general, continuous intraoperative MEP monitoring should be recommended in surgery of metastases in motor-eloquent brain regions. In contrast to data for glioma surgery, we would recommend using an amplitude decrease of 80% as the threshold to avoid resection-related motor deficits.
